Gallacher Capital Management LLC Purchases New Holdings in Mettler-Toledo International, Inc. (NYSE:MTD)

Gallacher Capital Management LLC bought a new position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 255 shares of the medical instruments supplier's stock, valued at approximately $301,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Commonwealth Equity Services LLC boosted its holdings in Mettler-Toledo International by 19.5% during the fourth quarter. Commonwealth Equity Services LLC now owns 706 shares of the medical instruments supplier's stock worth $864,000 after purchasing an additional 115 shares during the last quarter. Envestnet Portfolio Solutions Inc. boosted its holdings in Mettler-Toledo International by 5.8% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 513 shares of the medical instruments supplier's stock worth $628,000 after purchasing an additional 28 shares during the last quarter. TD Private Client Wealth LLC boosted its holdings in Mettler-Toledo International by 9.1% during the fourth quarter. TD Private Client Wealth LLC now owns 203 shares of the medical instruments supplier's stock worth $248,000 after purchasing an additional 17 shares during the last quarter. Mizuho Securities USA LLC boosted its holdings in Mettler-Toledo International by 45.3% during the fourth quarter. Mizuho Securities USA LLC now owns 2,000 shares of the medical instruments supplier's stock worth $2,447,000 after purchasing an additional 624 shares during the last quarter. Finally, Hillsdale Investment Management Inc. purchased a new position in Mettler-Toledo International during the fourth quarter worth about $746,000. 95.07% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the completion of the sale, the director owned 120 shares of the company's stock, valued at $139,191.60. This represents a 89.85% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.94% of the stock is owned by insiders.

Mettler-Toledo International Stock Performance

NYSE MTD traded down $4.70 on Friday, hitting $1,256.05. The stock had a trading volume of 39,649 shares, compared to its average volume of 174,410. The firm has a 50-day moving average of $1,181.58 and a 200-day moving average of $1,193.94. The company has a market capitalization of $26.10 billion, a price-to-earnings ratio of 31.31, a price-to-earnings-growth ratio of 3.86 and a beta of 1.37. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.17% and a negative return on equity of 556.22%. The company had revenue of $883.74 million for the quarter, compared to analyst estimates of $876.61 million. During the same quarter last year, the firm earned $8.89 EPS. The firm's quarterly revenue was down 4.6% compared to the same quarter last year. As a group, research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms recently weighed in on MTD. Jefferies Financial Group upgraded shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and cut their price target for the stock from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Robert W. Baird dropped their target price on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 22nd. Wall Street Zen cut shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price on the stock in a research note on Monday, April 7th. Finally, Barclays initiated coverage on shares of Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 target price on the stock. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $1,280.90.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.